Trump administration rushes to steady Kennedy’s HHS, with an eye on the midterms

Key Points:

• The Trump administration is urgently working to fill leadership vacancies within the US Department of Health and Human Services (HHS), aiming to stabilize agencies like the FDA amid recent turmoil and ahead of the November midterm elections.
• A new FDA commissioner nominee is expected to be selected within weeks, alongside a broader senior staff shakeup intended to improve agency relations with its workforce and the healthcare industry.
• The White House is also pushing for rapid confirmations of new leaders for the CDC and surgeon general positions, moving away from controversial figures aligned with HHS Secretary Robert F. Kennedy Jr.'s "Make America Healthy Again" movement.
• The administration is shifting HHS policy focus from contentious vaccine debates to more mainstream issues such as drug pricing and health insurance affordability, despite resistance from MAHA supporters who favored radical health system reforms.
• Leadership changes have sparked departures of key FDA officials, and the administration faces the challenge of finding candidates who can satisfy Trump, Kennedy, GOP lawmakers, and industry stakeholders while minimizing internal conflict.